While many studies have focused on generating high-fidelity synthetic images for beneficial applications, very few have ...

April 26 has officially become known as Diabetic Eye Screening Day in Pennsylvania. There will be free screenings to help ...

The following is a summary of “Recent advances and applications of optical coherence tomography angiography in diabetic ...

The National Electronics and Computer Technology Center (Nectec), the Department of Medical Services and Mahidol University and alliances have introduced a Medical AI Data Platform for data sharing ...

Authors defined metabolic syndrome as “the set of factors that increase the risk of cardiovascular disease and diabetes, such ...

EYLEA ® (aflibercept) Injection 2 mg is a prescription medicine approved for the treatment of patients with Wet Age-Related Macular Degeneration (AMD), Macular Edema following Retinal Vein Occlusion ...

Regulatory action was based on data from the Phase III QUASAR trial, which demonstrated that Eylea HD dosed every eight weeks ...

Regeneron (REGN) announces FDA review of sBLA for Eylea HD to treat macular edema and expand dosing. Read more here.

Dr. Michael Kapusta, MD, FRSCS, Ophthalmologist, talks about advanced (proliferative) diabetic retinopathy and pars plana ...

People with type 2 diabetes have a higher risk of developing high blood pressure. The exact link is unknown, but it’s thought to result from the two conditions having similar causes and risk ...

DME is an irreversible and progressive complication of diabetic retinopathy and is related to consistently having high blood sugar levels that damage nerves and blood vessels in the macula, the area ...

The system, called the LumineticsCore platform, uses FDA-cleared AI models to detect diabetic retinopathy from retinal images taken during a primary care visit. The AI delivers same-day diagnostic ...